TAE226, a dual inhibitor of focal adhesion kinase and insulin‐like growth factor‐I receptor, is effective for Ewing sarcoma

by Hiroshi Moritake, Yusuke Saito, Daisuke Sawa, Naoki Sameshima, Ai Yamada, Mariko Kinoshita, Sachiyo Kamimura, Takao Konomoto, Hiroyuki Nunoi
Published 2019-12-01